Banner - Collaborative Care Symposium
News
All NewsContributorsMoney Matters
Media
All VideosExpert InterviewsMedical World NewsPodcastsCase Based Roundtable SeriesCase of the QuarterEyeViewGrand RoundsInsightsRapid ReadoutViewpointsWhat’s Your WhEYE?
Conferences
Conference CoverageConference Listing
Events
More
Publications
Digital EditionEurope Ophthalmology TimesModern RetinaSupplements and Featured Publications
CME
Partners
Resources
Job BoardSponsored

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Publications
  • CME
  • Partners
  • Subscribe
  • Resources
  • AMD
  • Biosimilars
  • COVID-19
  • Cataract
    • Cataract Surgery
  • Cataract Therapeutics
  • Clinical Diagnosis
    • The Residency Report
    • iOpeners
    • NeuroOp Guru
  • Cornea
  • DME
  • Dry Eye
    • Dry Eye Awareness
  • Gene Therapy
  • Geographic Atrophy
  • IOL
    • IOL Advances
  • Imaging
  • Interventional Glaucoma
    • Glaucoma Awareness
    • Glaucoma Insights
    • Therapeutic Glaucoma
  • OCT
  • Ocular Allergy
  • Ocular Surface Disease
  • Optic Relief
  • Optometry
  • Pediatrics
  • Pharmacy
  • Practice Management
    • Indispensable
  • Presbyopia
  • Ptosis
  • Refractive
    • Refractive Surgery
  • Retina
  • Surgery
  • Technology
  • Therapeutics
  • Understanding Antibiotic Resistance
  • Workplace
Spotlight -
Retina
Advertisement

Steven R. Sarkisian Jr., MD, ABO

Advertisement

Articles by Steven R. Sarkisian Jr., MD, ABO

Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting

ASCRS 2025: Steven R. Sarkisian Jr., MD, ABO, envisions a future without glaucoma drops

BySteven R. Sarkisian Jr., MD, ABO,Sheryl Stevenson,Hattie Hayes
June 4th 2025

At the 2025 ASCRS meeting, Dr. Sarkisian presented 3-year data on the iDose TR from the FDA clinical trial.

Nitric Oxide and Its Important Role in the Trabecular Meshwork of Glaucoma Patients

BySteven R. Sarkisian Jr., MD, ABO
December 21st 2018
Advertisement

Latest Updated Articles

  • Nitric Oxide and Its Important Role in the Trabecular Meshwork of Glaucoma Patients
    Nitric Oxide and Its Important Role in the Trabecular Meshwork of Glaucoma Patients

    Published: December 21st 2018 | Updated:



Advertisement
Advertisement

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

1

Glaukos receives FDA approval for Epioxa topical therapy for keratoconus

2

Dompé's NAION program selected for FDA Commissioner’s National Priority Voucher Program

3

Aurion Biotech releases positive 12-month results from phase 1/2 CLARA trial

4

AAO 2025: Diana Do, MD, reviews the real-world use of aflibercept 8 mg

5

AAO 2025: Kenneth C. Fan, MD, sees vision gains with MCO-010 in Stargardt disease

  • About
  • Advertise
  • Privacy
  • Editorial Info
  • Editorial Board
  • Terms and Conditions
  • Contact Us
  • Do Not Sell My Personal Information
  • Job Board
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
EyeCare Network
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us